We are live on ! Find out more
GFPC

Global Financial Private Client Portfolio holdings

AUM $369M
1-Year Est. Return 34.4%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+34.4%
3 Year Est. Return
+90.44%
5 Year Est. Return
+102.17%
10 Year Est. Return
AUM
$115M
AUM Growth
+$20.5M
Cap. Flow
+$2.69M
Cap. Flow %
2.34%
Top 10 Hldgs %
33.25%
Holding
555
New
26
Increased
102
Reduced
172
Closed
47

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.06%
2 Technology 9.91%
3 Financials 8.74%
4 Consumer Staples 3.97%
5 Healthcare 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
26
Invesco QQQ Trust
QQQ
$474B
$964K 0.84%
3,849
+802
+26% +$180K
V icon
27
Visa
V
$693B
$890K 0.77%
4,593
+27
+0.6% +$4.93K
DIS icon
28
Walt Disney
DIS
$185B
$864K 0.75%
7,647
-27
-0.4% -$2.98K
XOM icon
29
ExxonMobil
XOM
$672B
$844K 0.73%
19,302
+76
+0.4% +$3.41K
HR icon
30
Healthcare Realty
HR
$6.34B
$837K 0.73%
31,064
-394
-1% -$10.1K
MBB icon
31
iShares MBS ETF
MBB
$38.9B
$828K 0.72%
7,489
+2,703
+56% +$299K
XLV icon
32
State Street Health Care Select Sector SPDR ETF
XLV
$43.5B
$805K 0.7%
7,984
+526
+7% +$51.9K
AMZN icon
33
Amazon
AMZN
$2.65T
$790K 0.69%
5,480
-20
-0.4% -$2.42K
CL icon
34
Colgate-Palmolive
CL
$69.4B
$779K 0.68%
10,673
-8,000
-43% -$568K
PG icon
35
Procter & Gamble
PG
$341B
$768K 0.67%
6,400
+732
+13% +$85.4K
PEP icon
36
PepsiCo
PEP
$183B
$767K 0.67%
5,793
+50
+0.9% +$6.59K
INTC icon
37
Intel
INTC
$534B
$727K 0.63%
12,368
-537
-4% -$32.1K
MRK icon
38
Merck
MRK
$358B
$713K 0.62%
9,569
+370
+4% +$27.9K
IYW icon
39
iShares US Technology ETF
IYW
$25B
$713K 0.62%
10,524
SGOL icon
40
abrdn Physical Gold Shares ETF
SGOL
$7.14B
$691K 0.6%
40,521
+14,771
+57% +$244K
ITA icon
41
iShares US Aerospace & Defense ETF
ITA
$12.7B
$671K 0.58%
8,228
+1,162
+16% +$91.7K
PGX icon
42
Invesco Preferred ETF
PGX
$3.67B
$644K 0.56%
45,391
+21,960
+94% +$308K
BA icon
43
Boeing
BA
$160B
$637K 0.55%
3,532
+168
+5% +$25.8K
CVX icon
44
Chevron
CVX
$415B
$634K 0.55%
7,240
+124
+2% +$11.1K
MA icon
45
Mastercard
MA
$497B
$623K 0.54%
2,070
-40
-2% -$11.3K
CVS icon
46
CVS Health
CVS
$117B
$610K 0.53%
9,442
+386
+4% +$24.3K
TOTL icon
47
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.86B
$580K 0.5%
11,739
-959
-8% -$47K
LDOS icon
48
Leidos
LDOS
$16.2B
$577K 0.5%
6,182
+520
+9% +$51.2K
SPDW icon
49
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.3B
$559K 0.49%
20,145
-771
-4% -$20.2K
BSCK
50
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
$556K 0.48%
26,155
-20,881
-44% -$444K

Similar funds

Global Financial Private Client's Q2 2020 Portfolio in Review

As of Q2 2020, Global Financial Private Client held 555 positions worth $115M, up 22% from $94.5M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Global Financial Private Client's Q2 2020 filing shows 26 new, 102 increased, 172 reduced and 47 closed positions. Its largest new stake was Schwab International Equity ETF: 281,900 shares worth $4.21M. The largest sale was Vanguard Morningstar Value ETF, an estimated $3.64M.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Financials.

  • Global Financial Private Client's largest Q2 2020 buy was Schwab International Equity ETF: 281,900 shares worth $4.21M.
  • Global Financial Private Client added most to Vanguard Intermediate-Term Bond ETF in Q2 2020, an estimated $2.16M increase.
  • Global Financial Private Client's biggest Q2 2020 reduction was Vanguard Morningstar Value ETF, cutting an estimated $3.64M.
  • Global Financial Private Client fully exited iShares Core MSCI EAFE ETF in Q2 2020, selling an estimated $1.99M.
  • Global Financial Private Client's ten largest holdings make up 33% of its $115M portfolio in Q2 2020.
  • Global Financial Private Client opened 26 new positions and closed 47 in Q2 2020.
  • Global Financial Private Client's portfolio value rose 22% quarter-over-quarter to $115M.

Based on Global Financial Private Client's 13F filing for Q2 2020, filed 16 May 2024.